ALLO - Allogene Therapeutics, Inc.
IEX Last Trade
2.16
-0.010 -0.463%
Share volume: 26,306
Last Updated: Fri 27 Dec 2024 06:30:15 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.32%
PREVIOUS CLOSE
CHG
CHG%
$2.17
-0.01
-0.46%
Summary score
12%
Profitability
0%
Dept financing
5%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-9.94%
Return on assets
-8.3%
Return on sales
-133148.17%
Return on invested capital
-27.56%
Total debt ratio
14.37%
Debt ratio change over timeo
-1.59%
Current Ratio
12.13%
Quick Ratio
11.06%
Cash Position Ratio
10.04%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.64%
Return on assets
-10.58%
Return on sales
-120475.3%
Return on invested capital
-42.09%
Total debt ratio
19.74%
Debt ratio change over timeo
-1.56%
Current Ratio
11.73%
Quick Ratio
11.73%
Cash Position Ratio
11.48%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-14.09%
Return on assets
-11.85%
Return on sales
-315927.27%
Return on invested capital
-40.6%
Total debt ratio
21.32%
Debt ratio change over time
-1.35%
Current Ratio
12.8%
Quick Ratio
12.8%
Cash Position Ratio
12.46%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-60.7%
Return on assets
-66.4%
Return on sales
516422.2%
Return on invested capital
6.96%
Total debt ratio
-159.13%
Debt ratio change over time
-1.59%
Current Ratio
-55%
Quick Ratio
-51.97%
Cash Position Ratio
-46.61%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALLO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.94% | 13.79% | 34.47% | 7.43% |
| Return on assets | -8.3% | 2.76% | 3.15% | 5.62% |
| Return on sales | -133148.17% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -27.56% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 14.37% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.59% | 308.97% | -6.99% | 1.18% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 11.73% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 11.73% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 11.48% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 10% | 23% |
| Short-term ratios | ALLO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.64% | 13.77% | 13.25% | 3.8% |
| Return on assets | -10.58% | 2.43% | 1.89% | 3.09% |
| Return on sales | -120475.3% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -42.09% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 19.74% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.56% | 46.38% | -72.08% | 1.51% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 11.73% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 11.73% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 11.48% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 11% | 28% |